Looking Beyond Recurrence: Comorbidities in Cancer Survivors

被引:38
作者
Edgington, Amy [1 ]
Morgan, Mary Ann [1 ]
机构
[1] Univ Calif Los Angeles, LIVESTRONGTM Survivorship Ctr Excellence, Los Angeles, CA 90095 USA
关键词
D O I
10.1188/11.CJON.E3-E12
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cancer recurrence is a very real concern for cancer survivors. Surveillance for recurrence and vigilance for development of new cancers are top priorities during follow-up visits after active treatment ends. However, the cancer survivor also is at risk for the development of comorbid conditions. These conditions, including obesity, diabetes, dyslipidemia, menopause, decreased bone mass, hypertension, and hypothyroidism, are discussed with their relevance for general health and their relationships to disease-specific cancers. All of these conditions should be routinely addressed as part of the patient's survivorship care when appropriate. The oncology nurse is in a prime position to educate survivors about the risks for these conditions, both through evidence-based practice guidelines specific to each condition and also through the use of a treatment summary and care plan. This article discusses these selected comorbidities and offers strategies for nurses to address them with survivors during follow-up visits. Clinical practice guidelines for comorbidities are included, along with oncology implications and relevance for survivors. Recommendations for modifiable risk factors and healthy living also are included, along with Web sites for survivorship care plans.
引用
收藏
页码:31 / 31
页数:1
相关论文
共 71 条
  • [1] Albini A., Pennesi G., Donatelli F., Cammarota R., de Flora S., Noonan D.M., Cardiotoxicity of anticancer drugs: The need for cardio-oncology and cardio-oncological prevention, Journal of the National Cancer Institute, 102, pp. 14-25, (2010)
  • [2] Alexander I., Pharmacotherapeutic management of osteoporosis and osteopenia, Nurse Practitioner, 34, 6, pp. 30-40, (2009)
  • [3] Thyroid Task Force. Medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism, Endocrine Practice, 8, pp. 457-469, (2002)
  • [4] Menopause Guidelines Revision Task Force. Medical guidelines for the clinical practice for the diagnosis and treatment of menopause, Endocrine Practice, 12, pp. 315-337, (2006)
  • [5] Diabetes Mellitus Clinical Practice Guidelines Task Force. Medical Guidelines for Clinical Practice for the Management of Diabetes Mellitus, (2007)
  • [6] Statement by an American Association of Clinical Endocrinologists Consensus Panel on Type 2 Diabetes: An Algorithm for Glycemic Control, (2009)
  • [7] American Cancer Society Guidelines on Diet and Cancer Prevention, (2010)
  • [8] Diabetes Basics: Type 2, (2010)
  • [9] Diagnosis and classification of diabetes mellitus, Diabetes Care, 33, SUPPL. 1, pp. 562-569, (2010)
  • [10] Executive summary: Standards of medical care in diabetes-2010, Diabetes Care, 33, SUPPL. 1, (2010)